23.07.2024 - 25.07.2024Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
Kongressthemen Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing companies entering into the ADC space and tackling toxicity, there is ever-increasing target and indication-competition. Considering the significant clinical setbacks witnessed in 2023, the demand to better understand the translatability of toxicities and develop more tolerable ADCs for achieving future clinical triumphs only grows stronger.
Wissenschaftliche Fach-Gesellschaft Hanson Wade Group
Kongressgebühr FULL PACKAGE: Conference + Workshop Day - Drug Developer: USD 4197.00,
Conference Only - Drug Developer: USD 2999.00,
FULL PACKAGE: Conference + Workshop Day - Solution Provider: USD 5097.00,
Conference Only - Solution Provider: USD 3699.00
Veranstalter Kontakt 83 Great Titchfield Street W1W 6RH London Großbritannien